However, high concentration 10 U/mL FXa treatment resulted in an almost twofold increase in DLD‐1 migration compared to control, and although clinical colorectal cancer FXa levels remain undetermined, this high concentration may better model the CRC hypercoagulable state. This evidence concerns the gene F10 and colorectal cancer.